Prognostic value of baseline and early treatment response of neutrophil-lymphocyte ratio, C-reactive protein, and lactate dehydrogenase in non-small cell lung cancer patients undergoing immunotherapy

BACKGROUND: Not all non-small cell lung cancer (NSCLC) patients will benefit from immune checkpoint therapy and use of these medications carry serious autoimmune adverse effects. Therefore, biomarkers are needed to better identify patients who will benefit from its use. Here, the correlation of over...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, MinDong, Jang, Won Seok, Kim, Hae Reong, Park, Ji Ae, Lim, Sun Min, Kim, Hye Ryun, Cho, Byoung Chul, Park, Yu Rang, Hong, Min Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413036/
https://www.ncbi.nlm.nih.gov/pubmed/37577328
http://dx.doi.org/10.21037/tlcr-23-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413036/
https://www.ncbi.nlm.nih.gov/pubmed/37577328
http://dx.doi.org/10.21037/tlcr-23-7

Ejemplares similares